A synthetic peptide fragment of thymosin beta-4, researched for wound healing and tissue repair.
Clinical ophthalmology (Auckland, N.Z.)|2015|Sosne G, Ousler G
BACKGROUND: The purpose of this study was to evaluate the safety and efficacy of thymosin beta 4 ophthalmic solution (RGN-259; Tβ4) in subjects with moderate to severe dry eye using the CAE™ model. METHODS: This single-center, prospective, double-mas…
PMID: 26056426
Chinese medical journal|2015|Wang Y et al.
BACKGROUND: Thymosin beta-4 (TB-4) is considered key roles in tissue development, maintenance and pathological processes. The study aimed to prove TB-4 positive biological function on nucleus pulposus (NP) cell apoptosis and slowing the process of ce…
PMID: 26021512
Molecular oncology|2015|Cheung B et al.
Retinoids are an important component of neuroblastoma therapy at the stage of minimal residual disease, yet 40-50% of patients treated with 13-cis-retinoic acid (13-cis-RA) still relapse, indicating the need for more effective retinoid therapy. Vorin…
PMID: 25963741
Journal of diabetes research|2015|Wang L et al.
Peripheral neuropathy is a chronic complication of diabetes mellitus. To investigated the efficacy and safety of the extended treatment of diabetic peripheral neuropathy with thymosin β4 (Tβ4), male diabetic mice (db/db) at the age of 24 weeks were t…
Animal StudyIn Vitro
PMID: 25945352
PloS one|2015|Piludu M et al.
Due to its actin-sequestering properties, thymosin beta-4 (Tβ4) is considered to play a significant role in the cellular metabolism. Several physiological properties of Tβ4 have been reported;, however, many questions concerning its cellular function…
Animal Study
PMID: 25835495
Expert opinion on biological therapy|2015|Knop J et al.
INTRODUCTION: The purpose of our work was to identify unknown interaction partners of thymosin β4 (Tβ4). It was suggested that Tβ4 could be an antifibrotic drug for treatment of liver fibrogenesis, because Tβ4 prevents the platelet-derived growth fac…
In Vitro
PMID: 26096218
PloS one|2015|Kim J et al.
Although the various biological roles of thymosin β4 (Tβ4) have been studied widely, the effect of Tβ4 and Tβ4-expressing cells in the liver remains unclear. Therefore, we investigated the expression and function of Tβ4 in chronically damaged livers.…
Animal Study
PMID: 25826335
International journal of molecular medicine|2015|Someya H et al.
In previous studies by our group, we reported that thymosin beta 4 (Tb4) is closely associated with the initiation and development of the tooth germ, and can induce the expression of runt-related transcription factor 2 (RUNX2) during the development…
Animal StudyIn Vitro
PMID: 25739055
Molecular medicine reports|2015|Fu X et al.
Hepatoblastoma (HB) is the most common malignant hepatic tumor in children and complete surgical resection offers the highest possibility for cure in this disease. Tumor metastasis is the principle obstacle to the development of efficient treatments…
In Vitro
PMID: 25695679
Biomolecules & therapeutics|2015|Ryu Y, Lee J, Moon E
Vascular endothelial growth factor (VEGF) is an important regulator of neovascularization. Hypoxia inducible nitric oxide (NO) enhanced the expression of VEGF and thymosin beta-4 (Tβ4), actin sequestering protein. Here, we investigated whether NO-med…
In Vitro
PMID: 25593639
Expert opinion on biological therapy|2015|Vasilopoulou E et al.
Therapies that modulate inflammation and fibrosis have the potential to reduce the morbidity and mortality associated with chronic kidney disease (CKD). A promising avenue may be manipulating thymosin-β4, a naturally occurring peptide, which is the m…
PMID: 26096077
PloS one|2015|Unknown authors
[This corrects the article DOI: 10.1371/journal.pone.0110598.].
Animal Study
PMID: 25695660
Journal of nanoscience and nanotechnology|2015|Choi B et al.
Titanium (Ti) is the most widely used implant material in dentistry and orthopedics but the release of metal ions from Ti implants results in increased bone resorption by enhancing the production of inflammatory cytokines from the macrophages and fac…
PMID: 26369135
Tissue engineering. Part A|2015|Ti D et al.
It is important to establish an efficient vascularization for the long-term acceptance of bioengineered skin equivalents treating the cutaneous wounds of diabetic rats with hindlimb ischemia. This study investigates the possible use of a collagen-chi…
Animal StudyIn Vitro
PMID: 25204972
Neuroreport|2015|Zhou T et al.
Neuroinflammation mediated by activated microglia plays a pivotal role in the pathogenesis of neurological disorders, including hypoxic injury of the developing brain. Thymosin β4 (Tβ4), the major G-actin-sequestering molecule, has an anti-inflammato…
Animal StudyIn Vitro
PMID: 26457369
Expert opinion on biological therapy|2015|Sosne G, Kim C, Kleinman H
OBJECTIVE: Dry eye syndrome is a common condition that affects up to 20% of the population aged 45 and older. There are no successful treatments to date. The goal of this research was to determine the efficacy of various doses and the optimal frequen…
Animal Study
PMID: 26096547
Annals of biomedical engineering|2015|Wong S et al.
Skeletal muscles often experience oxidative stress in anaerobic metabolism and ischemia-reperfusion. This paper reports how oxidative stress affects the stiffness of cultured murine myotubes and their actin filaments polymerization dynamics. H2O2 was…
Animal Study
PMID: 25371376
Differentiation; research in biological diversity|2015|Lee S et al.
A recent report showed that thymosin beta-4 (Tβ4) is expressed during the development of tooth germ, but its effect on osteoblastic/cementoblastic differentiation is a controversial topic. Furthermore, the precise expression and function of Tβ4 in pe…
Animal Study
PMID: 26361868
Cell reports|2015|Vitriol E et al.
Lamellipodia, the sheet-like protrusions of motile cells, consist of networks of actin filaments (F-actin) regulated by the ordered assembly from and disassembly into actin monomers (G-actin). Traditionally, G-actin is thought to exist as a homogeneo…
PMID: 25865895
Current pharmaceutical design|2015|Hrenak J, Paulis L, Simko F
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) is a ubiquitous molecule generated in all mammalian tissues from the N-terminal sequence of thymosin β4 (Tβ4) by the action of propyl oligopeptidase. Ac-SDKP is an alternative substrate for angiotensin…
Review
PMID: 26350537